TOFRANIL Side Effects

6972296-3 | Aphasia, Autonomic Nervous System Imbalance, Blood Creatine Phosphokinase Increased, Cognitive Disorder, Consciousness Fluctuating, Dementia With Lewy Bodies, Disorientation, Disturbance In Attention
on Aug 25, 2010 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), autonomic nervous system imbalance, blood creatine phosphokinase increased, cognitive disorder, consciousness fluctuating, dementia with lewy bodies, disorientation, disturbance in attention. Tofranil dosage: 30 Mg, Unk. During the same period patient was treated with PARLODEL (Unk) (View Parlodel Review and Parlodel Label ), LITHIUM CARBONATE (300 Mg, Unk) (View Lithium Carbonate Review and Lithium Carbonate Label ), LEVOMEPROMAZINE (1 Mg, Unk) (View Levomepromazine Review and Levomepromazine Label ), RISPERIDONE (1 Mg, Unk) (View Risperidone Review and Risperidone Label ), DANTRIUM (80 Mg, Qd) (View Dantrium Review and Dantrium Label ), DONEPEZIL HYDROCHLORIDE (Unk) (View Donepezil Hydrochloride Review and Donepezil Hydrochloride Label ). Patient was hospitalized.

6959413-6 | Convulsion, Product Substitution Issue
Patient was taking Tofranil (View Usage). Patient had the following side effects: convulsion, product substitution issue on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 190.4 lb, was diagnosed with convulsion and. Tofranil dosage: .

6922578-6 | Aphasia, Autonomic Nervous System Imbalance, Blood Creatine Phosphokinase Increased, Cognitive Disorder, Consciousness Fluctuating, Dementia With Lewy Bodies, Disorientation, Disturbance In Attention, Extrapyramidal Disorder
Adverse event was reported on Jul 29, 2010 by a Female patient taking Tofranil (View Usage) (Dosage: 30 Mg, Unk) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: JAPAN , 68 years of age, After Tofranil was administered, patient had the following side effects: aphasia (What is aphasia?), autonomic nervous system imbalance, blood creatine phosphokinase increased, cognitive disorder, consciousness fluctuating, dementia with lewy bodies, disorientation, disturbance in attention, extrapyramidal disorder. During the same period patient was treated with LITHIUM CARBONATE (300 Mg, Unk) (View Lithium Carbonate Review and Lithium Carbonate Label ), LEVOMEPROMAZINE (1 Mg, Unk) (View Levomepromazine Review and Levomepromazine Label ), RISPERIDONE (1 Mg, Unk) (View Risperidone Review and Risperidone Label ), DANTRIUM (80 Mg, Qd) (View Dantrium Review and Dantrium Label ). Patient was hospitalized.

6905990-0 | Neuroleptic Malignant Syndrome, Platelet Count Decreased, Pyrexia
on Jul 21, 2010 Female patient from JAPAN , 68 years of age, was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome, platelet count decreased, pyrexia. Tofranil dosage: Unk. During the same period patient was treated with PARLODEL (Unk) (View Parlodel Review and Parlodel Label ). Patient was hospitalized.


6638438-4 | Bladder Spasm, Incontinence, Product Substitution Issue
on Mar 16, 2010 Female patient from UNITED STATES , weighting 175.0 lb, was diagnosed with bladder spasm, incontinence and was treated with Tofranil (View Usage). Patient had the following side effects: bladder spasm, incontinence, product substitution issue. Tofranil dosage: 3 Tab 2 X Day Oral 1 Week With Both Tab And 1 Wk Only Circle Tab..

6621494-7 | Off Label Use, Thrombocytopenia
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: off label use, thrombocytopenia on Feb 24, 2010 from TURKEY Additional patient health information: Male patient , child 5 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Tofranil dosage: 10 Mg, Qd.

6381734-9 | Anxiety, Coordination Abnormal, Dizziness, Hypokinesia, Irritability, Movement Disorder, Pain, Self Injurious Behaviour, Sleep Disorder
Adverse event was reported on Sep 22, 2009 by a Male patient taking Tofranil (View Usage) (Dosage: 25 Mg, 8qd) was diagnosed with depression (What is depression?) and. Location: BRAZIL , 35 years of age, weighting 213.8 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), coordination abnormal, dizziness (What is dizziness?), hypokinesia, irritability, movement disorder (What is movement disorder?), pain (What is pain?), self injurious behaviour, sleep disorder (What is sleep disorder?).

6089718-5 | Rash
on Feb 20, 2009 Female patient from UNITED STATES , weighting 115.0 lb, was diagnosed with major depression and was treated with Tofranil (View Usage). Patient had the following side effects: rash (What is rash?). Tofranil dosage: 10 Mg Once Daily Po (duration: A Week).

6075272-0 | Anorexia, Anxiety, Depression, Disturbance In Attention, Hyperhidrosis, Impaired Work Ability, Nausea, Somnolence, Tachycardia
on Feb 02, 2009 Female patient from BRAZIL , 57 years of age, weighting 149.9 lb, was diagnosed with urge incontinence and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: anorexia, anxiety (What is anxiety?), depression (What is depression?), disturbance in attention, hyperhidrosis, impaired work ability, nausea (What is nausea?), somnolence, tachycardia. Tofranil dosage: 1 Df, Qd.

6063093-4 | Arteriogram Coronary Abnormal, Blood Alkaline Phosphatase Increased, Cardiac Failure, Cardiomegaly, Coronary Artery Stenosis, Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased, Electrocardiogram Abnormal
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: arteriogram coronary abnormal, blood alkaline phosphatase increased, cardiac failure, cardiomegaly, coronary artery stenosis, dilatation ventricular, dyspnoea, ejection fraction decreased, electrocardiogram abnormal on Jan 22, 2009 from JAPAN Additional patient health information: Female patient , weighting 92.59 lb, was diagnosed with depression (What is depression?), prophylaxis against gastrointestinal ulcer, insomnia and. Tofranil dosage: 25 Mg, 2 Tablets Tid. During the same period patient was treated with PLETAL (View Pletal Review and Pletal Label ), GASTER (40 Mg) (View Gaster Review and Gaster Label ), PROTHIADEN (50 Mg, Unk) (View Prothiaden Review and Prothiaden Label ), DIURETICS (Unk) (View Diuretics Review and Diuretics Label ), ANGIOTENSIN II (View Angiotensin Ii Review and Angiotensin Ii Label ), LENDORMIN (0.25 Mg) (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6054560-8 | Arteriogram Coronary Abnormal, Blood Alkaline Phosphatase Increased, Cardiac Failure, Cardiomegaly, Coronary Artery Stenosis, Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased, Electrocardiogram Abnormal
Adverse event was reported on Jan 22, 2009 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg, 2 Tablets Tid) was diagnosed with depression (What is depression?), prophylaxis against gastrointestinal ulcer, insomnia and. Location: UNITED KINGDOM , weighting 92.59 lb, Patient had the following side effects: arteriogram coronary abnormal, blood alkaline phosphatase increased, cardiac failure, cardiomegaly, coronary artery stenosis, dilatation ventricular, dyspnoea, ejection fraction decreased, electrocardiogram abnormal. During the same period patient was treated with PLETAL (View Pletal Review and Pletal Label ), GASTER (40 Mg) (View Gaster Review and Gaster Label ), PROTHIADEN (50 Mg, Unk) (View Prothiaden Review and Prothiaden Label ), DIURETICS (Unk) (View Diuretics Review and Diuretics Label ), ANGIOTENSIN II (View Angiotensin Ii Review and Angiotensin Ii Label ), LENDORMIN (0.25 Mg) (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6026973-1 | Blood Alkaline Phosphatase Increased, Cardiac Failure, Cardiomegaly, Coronary Artery Stenosis, Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased, Electrocardiogram Abnormal, Gamma-glutamyltransferase Increased
on Dec 25, 2008 Female patient from JAPAN , weighting 92.59 lb, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: blood alkaline phosphatase increased, cardiac failure, cardiomegaly, coronary artery stenosis, dilatation ventricular, dyspnoea, ejection fraction decreased, electrocardiogram abnormal, gamma-glutamyltransferase increased. Tofranil dosage: 25 Mg, 2 Tablets Tid. During the same period patient was treated with PLETAL (View Pletal Review and Pletal Label ), GASTER (40 Mg) (View Gaster Review and Gaster Label ), PROTHIADEN (View Prothiaden Review and Prothiaden Label ), DIURETICS (Unk) (View Diuretics Review and Diuretics Label ), ANGIOTENSIN II (View Angiotensin Ii Review and Angiotensin Ii Label ), PROTHIADEN /NET/ (50 Mg) (View Prothiaden /net/ Review and Prothiaden /net/ Label ), LENDORMIN (0.25 Mg) (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6023510-2 | Somnolence, Suicide Attempt, Vomiting
on Dec 21, 2008 Male patient from BRAZIL , 25 years of age, was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: somnolence, suicide attempt, vomiting. Tofranil dosage: 1 Tablet. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (Unk) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ALPRAZOLAM (23 Tablets) (View Alprazolam Review and Alprazolam Label ), TRANYLCYPROMINE SULFATE (2 Tabs) (View Tranylcypromine Sulfate Review and Tranylcypromine Sulfate Label ). Patient was hospitalized.

6003758-3 | Abdominal Pain Upper, Dehydration, Somnolence, Vomiting
Patient was taking Tofranil (View Usage). Patient had the following side effects: abdominal pain upper, dehydration, somnolence, vomiting on Dec 04, 2008 from BRAZIL Additional patient health information: Male patient , child 9 years of age, weighting 70.55 lb, was diagnosed with attention deficit/hyperactivity disorder and. Tofranil dosage: 50 Mg, Qd. During the same period patient was treated with DIVALPROEX SODIUM (500 Mg, Unk) (View Divalproex Sodium Review and Divalproex Sodium Label ).

5990659-X | Bladder Mass, Chromaturia, Dysuria
Adverse event was reported on Nov 28, 2008 by a Female patient taking Tofranil (View Usage) (Dosage: Unk) was diagnosed with enuresis, hyperlipidaemia and. Location: JAPAN , 73 years of age, After Tofranil was administered, patient had the following side effects: bladder mass, chromaturia, dysuria. During the same period patient was treated with MEVALOTIN (View Mevalotin Review and Mevalotin Label ).

5982606-1 | Cardiac Failure, Dyspnoea, Palpitations
on Nov 28, 2008 Female patient from JAPAN , 65 years of age, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, dyspnoea, palpitations. Tofranil dosage: Unk. During the same period patient was treated with PLETAL (View Pletal Review and Pletal Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), PROTHIADEN (View Prothiaden Review and Prothiaden Label ). Patient was hospitalized.

5980326-0 | Depression, Headache, Insomnia
on Nov 28, 2008 Male patient from BRAZIL , 63 years of age, weighting 200.6 lb, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). Patient had the following side effects: depression (What is depression?), headache (What is headache?), insomnia. Tofranil dosage: 25 Mg, Qd. During the same period patient was treated with TRYPTANOL (75 Mg, Qd) (View Tryptanol Review and Tryptanol Label ).

5980269-2 | Hypotonia, Insomnia, Irritability, Nervousness, Vulvovaginal Dryness
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: hypotonia, insomnia, irritability, nervousness, vulvovaginal dryness on Nov 26, 2008 from BRAZIL Additional patient health information: Female patient , 38 years of age, weighting 136.7 lb, was diagnosed with headache (What is headache?), irritability, nervousness and. Tofranil dosage: 1 Tab Every 12 Hours. During the same period patient was treated with PHENOBARBITAL TAB (1/2 Tab A Day) (View Phenobarbital Tab Review and Phenobarbital Tab Label ).

5972971-3 | Cardiac Failure, Parkinson's Disease
Adverse event was reported on Nov 25, 2008 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg/day) was diagnosed with pollakiuria and. Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure, parkinson's disease (What is parkinson's disease?). Patient was hospitalized.

5970894-7 | Aggression, Attention Deficit/hyperactivity Disorder, Mydriasis, Nervousness, Pallor
on Nov 17, 2008 Male patient from BRAZIL , child 9 years of age, weighting 88.18 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Tofranil (View Usage). Patient had the following side effects: aggression, attention deficit/hyperactivity disorder, mydriasis, nervousness, pallor. Tofranil dosage: 10 Mg, Qd.

5967629-0 | Accidental Exposure, Tachycardia
on Nov 17, 2008 Male patient from BRAZIL , child 8 years of age, was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: accidental exposure, tachycardia. Tofranil dosage: 75 Mg, Once/single. Patient was hospitalized.

5965012-5 | Parkinson's Disease
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: parkinson's disease (What is parkinson's disease?) on Nov 13, 2008 from JAPAN Additional patient health information: Female patient , 77 years of age, . Tofranil dosage: .

5941807-9 | Blood Pressure Decreased, Surgery
Adverse event was reported on Oct 30, 2008 by a Male patient taking Tofranil (View Usage) (Dosage: 100 Mg Daily) was diagnosed with benign prostatic hyperplasia, pollakiuria, hypertension and. Location: JAPAN , weighting 163.1 lb, Patient had the following side effects: blood pressure decreased, surgery (What is surgery?). During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), CASODEX (View Casodex Review and Casodex Label ), VESICARE (10 Mg) (View Vesicare Review and Vesicare Label ), ALDOMET (500 Mg) (View Aldomet Review and Aldomet Label ), ANAESTHETICS (View Anaesthetics Review and Anaesthetics Label ).

5940977-6 | Hypotonia, Insomnia, Irritability, Nervousness, Vulvovaginal Dryness
on Oct 28, 2008 Female patient from BRAZIL , 38 years of age, weighting 136.7 lb, was diagnosed with headache (What is headache?), irritability, nervousness and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: hypotonia, insomnia, irritability, nervousness, vulvovaginal dryness. Tofranil dosage: 1 Tab Every 12 Hours. During the same period patient was treated with PHENOBARBITAL TAB (1/2 Tab A Day) (View Phenobarbital Tab Review and Phenobarbital Tab Label ).

5931929-0 | Agitation, Cough, Insomnia, Restlessness, Rhinitis, Sinusitis, Sneezing, Weight Decreased
on Oct 15, 2008 Male patient from BRAZIL , 37 years of age, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, cough, insomnia, restlessness, rhinitis, sinusitis (What is sinusitis?), sneezing, weight decreased. Tofranil dosage: 25 Mg, Qd. During the same period patient was treated with HALDOL (5 Mg, 1 Tablet At Night) (View Haldol Review and Haldol Label ), PROMETHAZINE (25 Mg) (View Promethazine Review and Promethazine Label ), BIPERIDEN HYDROCHLORIDE TAB (2 Mg, 1 Tablet I The Morning) (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ).

5930515-6 | Blood Pressure Decreased, Surgery
Patient was taking Tofranil (View Usage). Patient had the following side effects: blood pressure decreased, surgery (What is surgery?) on Oct 17, 2008 from JAPAN Additional patient health information: Male patient , weighting 163.1 lb, was diagnosed with benign prostatic hyperplasia, pollakiuria, hypertension, dementia (What is dementia?) and. Tofranil dosage: 100 Mg Daily. During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), CASODEX (View Casodex Review and Casodex Label ), VESICARE (10 Mg) (View Vesicare Review and Vesicare Label ), ALDOMET (500 Mg) (View Aldomet Review and Aldomet Label ), ANAESTHETICS (View Anaesthetics Review and Anaesthetics Label ).

5923988-6 | Micturition Urgency, Musculoskeletal Discomfort, Nephrolithiasis, Premature Ejaculation, Urethral Disorder, Urinary Tract Infection
Adverse event was reported on Oct 09, 2008 by a Male patient taking Tofranil (View Usage) (Dosage: 10mg 1 Tablet Per Day) was diagnosed with depression (What is depression?), anxiety (What is anxiety?), hypertension and. Location: BRAZIL , weighting 158.7 lb, After Tofranil was administered, patient had the following side effects: micturition urgency, musculoskeletal discomfort, nephrolithiasis, premature ejaculation, urethral disorder, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with OLCADIL (1mg, 1 Tablet Per Day) (View Olcadil Review and Olcadil Label ), PHARMATON (1 Tablet Per Day) (View Pharmaton Review and Pharmaton Label ), ATENOLOL (25mg, 1 Tablet Per Day) (View Atenolol Review and Atenolol Label ).

5911960-1 | Hypokinesia, Movement Disorder, Vertigo, Vision Blurred
on Sep 30, 2008 Male patient from BRAZIL , 33 years of age, was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: hypokinesia, movement disorder (What is movement disorder?), vertigo, vision blurred. Tofranil dosage: 25 Mg, Unk.

5911948-0 | Aggression, Fear, Insomnia, Pigmentation Disorder, Vision Blurred
on Sep 29, 2008 Male patient from BRAZIL , weighting 54.23 lb, was diagnosed with psychomotor hyperactivity and was treated with Tofranil (View Usage). Patient had the following side effects: aggression, fear, insomnia, pigmentation disorder, vision blurred. Tofranil dosage: 1 Tablet At 17h00.

5911941-8 | Aggression, Fear, Insomnia, Pigmentation Disorder, Vision Blurred
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: aggression, fear, insomnia, pigmentation disorder, vision blurred on Sep 29, 2008 from BRAZIL Additional patient health information: Male patient , weighting 49.25 lb, was diagnosed with psychomotor hyperactivity and. Tofranil dosage: 25 Mg, Qd.

5894890-3 | Aggression, Fear, Insomnia, Pigmentation Disorder, Skin Discolouration, Vision Blurred
Adverse event was reported on Sep 12, 2008 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg/day) was diagnosed with psychomotor hyperactivity and. Location: BRAZIL , weighting 49.25 lb, Patient experienced the following unwanted or unexpected effects: aggression, fear, insomnia, pigmentation disorder, skin discolouration, vision blurred.

5890508-4 | Suicide Attempt
on Sep 15, 2008 Female patient from BRAZIL , 14 years of age, weighting 132.3 lb, was treated with Tofranil (View Usage). Patient had the following side effects: suicide attempt. Tofranil dosage: Unk. During the same period patient was treated with PHENOBARBITAL TAB (Unk) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), TRYPTOPHAN (Unk) (View Tryptophan Review and Tryptophan Label ), OXYBUTYIN CHLORIDE (Unk) (View Oxybutyin Chloride Review and Oxybutyin Chloride Label ).

5888914-7 | Aggression, Fear, Insomnia, Pigmentation Disorder, Vision Blurred
on Sep 12, 2008 Male patient from BRAZIL , weighting 54.23 lb, was diagnosed with psychomotor hyperactivity and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: aggression, fear, insomnia, pigmentation disorder, vision blurred. Tofranil dosage: 1 Tablet At 17h00.

5886657-7 | Hyperhidrosis, Initial Insomnia, Myoclonus, Serotonin Syndrome, Tachycardia, Tremor
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis, initial insomnia, myoclonus, serotonin syndrome, tachycardia, tremor on Sep 09, 2008 from JAPAN Additional patient health information: Male patient , 30 years of age, was diagnosed with depression (What is depression?) and. Tofranil dosage: 50 Mg/day. During the same period patient was treated with PAXIL (30 Mg/day) (View Paxil Review and Paxil Label ), ZOLOFT (100 Mg/day) (View Zoloft Review and Zoloft Label ), LUVOX (Unk) (View Luvox Review and Luvox Label ), SSRI (View Ssri Review and Ssri Label ).

5886656-5 | Hyperhidrosis, Initial Insomnia, Myoclonus, Serotonin Syndrome, Tachycardia, Tremor
Adverse event was reported on Sep 09, 2008 by a Male patient taking Tofranil (View Usage) (Dosage: 50 Mg/day) was diagnosed with depression (What is depression?) and. Location: JAPAN , 30 years of age, Patient had the following side effects: hyperhidrosis, initial insomnia, myoclonus, serotonin syndrome, tachycardia, tremor. During the same period patient was treated with PAXIL (30 Mg/day) (View Paxil Review and Paxil Label ), ZOLOFT (100 Mg/day) (View Zoloft Review and Zoloft Label ), LUVOX (Unk) (View Luvox Review and Luvox Label ), SSRI (View Ssri Review and Ssri Label ).

5883545-7 | Abnormal Behaviour, Aggression, Antisocial Behaviour, Bedridden, Blood Cholesterol Increased, Blood Glucose Abnormal, Blood Triglycerides Increased, Crying, Depression
on Sep 08, 2008 Male patient from BRAZIL , 52 years of age, weighting 191.8 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: abnormal behaviour, aggression, antisocial behaviour, bedridden, blood cholesterol increased, blood glucose abnormal, blood triglycerides increased, crying, depression (What is depression?). Tofranil dosage: 10 Mg. During the same period patient was treated with RIVOTRIL (8 Drops Before Sleeping) (View Rivotril Review and Rivotril Label ).

5852329-8 | Depression, Gastric Lavage, Somnolence, Suicide Attempt
on Aug 19, 2008 Female patient from BRAZIL , 35 years of age, weighting 264.6 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), gastric lavage, somnolence, suicide attempt. Tofranil dosage: 75 Mg, Bid. During the same period patient was treated with TEGRETOL (400 Mg, Bid) (View Tegretol Review and Tegretol Label ), CARBOLITIUM CR (450 Mg, Bid) (View Carbolitium Cr Review and Carbolitium Cr Label ), RISPERIDONE (4 Mg, Qd (bedtime)) (View Risperidone Review and Risperidone Label ).

5850952-8 | Abnormal Behaviour, Crying, Decreased Activity, Depression, Hallucination, Suicidal Ideation
Patient was taking Tofranil (View Usage). Patient had the following side effects: abnormal behaviour, crying, decreased activity, depression (What is depression?), hallucination, suicidal ideation on Aug 15, 2008 from BRAZIL Additional patient health information: Male patient , 14 years of age, was diagnosed with nervousness, agitation, sleep disorder (What is sleep disorder?), limb injury and. Tofranil dosage: 1 Df/day. During the same period patient was treated with NEOZINE (40 Mg, 12 Drops Before Sleeping) (View Neozine Review and Neozine Label ), AZITHROMYCIN (500 Mg) (View Azithromycin Review and Azithromycin Label ), PIROXICAM (50 Mg, 1 Tablet/8 Hours) (View Piroxicam Review and Piroxicam Label ), POTASSIUM PERMANGANATE (Unk) (View Potassium Permanganate Review and Potassium Permanganate Label ), PIRACETAM (View Piracetam Review and Piracetam Label ), CINNARIZINE (View Cinnarizine Review and Cinnarizine Label ).

5834279-6 | Altered State Of Consciousness, Blood Pressure Increased, Convulsion, Diarrhoea, Hyperglycaemia, Hyperpyrexia, Hyperthyroidism, Intentional Overdose, Renal Impairment
Adverse event was reported on Jul 30, 2008 by a Male patient taking Tofranil (View Usage) (Dosage: 2100 Mg, Once/single) . Location: JAPAN , 30 years of age, After Tofranil was administered, patient had the following side effects: altered state of consciousness, blood pressure increased, convulsion, diarrhoea, hyperglycaemia, hyperpyrexia, hyperthyroidism, intentional overdose, renal impairment. During the same period patient was treated with LITHIUM CARBONATE (36800 Mg, Once/single) (View Lithium Carbonate Review and Lithium Carbonate Label ), AMOXAPINE (2100 Mg, Once/single) (View Amoxapine Review and Amoxapine Label ). Patient was hospitalized.

5758894-3 | Blood Pressure Decreased, Cardiac Arrest, Cardio-respiratory Arrest, Clonic Convulsion, Electrocardiogram Abnormal, Electrocardiogram Qrs Complex Prolonged, Electromechanical Dissociation, Heart Rate Decreased
on May 29, 2008 Female patient from JAPAN , 40 years of age, was diagnosed with depression (What is depression?), suicide attempt, borderline personality disorder and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, clonic convulsion, electrocardiogram abnormal, electrocardiogram qrs complex prolonged, electromechanical dissociation, heart rate decreased. Tofranil dosage: Unk, Unk. Patient was hospitalized.

5751668-9 | Blood Pressure Decreased, Cardiac Arrest, Cardio-respiratory Arrest, Clonic Convulsion, Electrocardiogram Abnormal, Electrocardiogram Qrs Complex Prolonged, Electromechanical Dissociation, Heart Rate Decreased
on May 21, 2008 Female patient from JAPAN , 40 years of age, was diagnosed with depression (What is depression?), suicide attempt, borderline personality disorder and was treated with Tofranil (View Usage). Patient had the following side effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, clonic convulsion, electrocardiogram abnormal, electrocardiogram qrs complex prolonged, electromechanical dissociation, heart rate decreased. Tofranil dosage: Unk, Unk. Patient was hospitalized.

5751560-X | Asthenopia, Scotoma, Tremor, Vision Blurred
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: asthenopia, scotoma, tremor, vision blurred on May 19, 2008 from BRAZIL Additional patient health information: Male patient , 33 years of age, weighting 132.3 lb, was diagnosed with affective disorder, somnolence and. Tofranil dosage: Unk Df, Unk. During the same period patient was treated with RIVOTRIL (0.5 Mg Once At Night) (View Rivotril Review and Rivotril Label ), AMITRIPTYLINE HCL (Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5714134-2 | Abdominal Pain, Agitation, Alopecia, Arrhythmia, Constipation, Dry Mouth, Ear Operation, Euphoric Mood, Feeling Hot
Adverse event was reported on Apr 15, 2008 by a Female patient taking Tofranil (View Usage) (Dosage: ) was diagnosed with panic disorder (What is panic disorder?), nervousness, hypertension and. Location: BRAZIL , 30 years of age, weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), agitation, alopecia, arrhythmia (What is arrhythmia?), constipation (What is constipation?), dry mouth, ear operation, euphoric mood, feeling hot. During the same period patient was treated with LORAX (1 Mg, Bid) (View Lorax Review and Lorax Label ), ATENOLOL W/CHLORTALIDONE (100/25 Mg/day) (View Atenolol W/chlortalidone Review and Atenolol W/chlortalidone Label ).

5703698-0 | Blood Pressure Decreased, Cardiac Arrest, Clonic Convulsion, Electrocardiogram Abnormal, Electrocardiogram Qrs Complex Prolonged, Electromechanical Dissociation, Heart Rate Decreased, Intentional Overdose
on Apr 04, 2008 Female patient from JAPAN , 40 years of age, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). Patient had the following side effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), clonic convulsion, electrocardiogram abnormal, electrocardiogram qrs complex prolonged, electromechanical dissociation, heart rate decreased, intentional overdose. Tofranil dosage: Unk, Unk. Patient was hospitalized.

5676108-X | Burning Sensation, Depression, Muscle Rigidity, Pain In Extremity, Vein Disorder
on Mar 13, 2008 Male patient from , 31 years of age, weighting 180.8 lb, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: burning sensation, depression (What is depression?), muscle rigidity, pain in extremity, vein disorder. Tofranil dosage: 1 Df, Qhs.

5669713-8 | Parkinson's Disease
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: parkinson's disease (What is parkinson's disease?) on Mar 07, 2008 from JAPAN Additional patient health information: Male patient , 71 years of age, . Tofranil dosage: 25 Mg/day. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), EURODIN (2 Mg) (View Eurodin Review and Eurodin Label ), BETAMAC (50 Mg) (View Betamac Review and Betamac Label ), ESIDRI (View Esidri Review and Esidri Label ).

5650738-3 | Asthenopia, Scotoma, Vision Blurred
Adverse event was reported on Feb 26, 2008 by a Male patient taking Tofranil (View Usage) (Dosage: 75 Mg/day) was diagnosed with affective disorder and. Location: BRAZIL , 33 years of age, weighting 132.3 lb, Patient had the following side effects: asthenopia, scotoma, vision blurred. During the same period patient was treated with RIVOTRIL (View Rivotril Review and Rivotril Label ).

5578606-6 | Arrhythmia, Blood Pressure Decreased, Cardio-respiratory Arrest, Depressed Level Of Consciousness, Glossoptosis, Intubation, Life Support, Overdose, Shock
on Dec 28, 2007 Female patient from JAPAN , 32 years of age, weighting 99.21 lb, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), blood pressure decreased, cardio-respiratory arrest, depressed level of consciousness, glossoptosis, intubation, life support, overdose, shock. Tofranil dosage: . During the same period patient was treated with TRIAZOLAM (3.25 Mg, Once/single) (View Triazolam Review and Triazolam Label ), CLOXAZOLAM (172 Mg, Once/single) (View Cloxazolam Review and Cloxazolam Label ), BROMAZEPAM (50 Mg, Once/single) (View Bromazepam Review and Bromazepam Label ), FLUNITRAZEPAM (20 Mg, Once/single) (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

5577612-5 | Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Decreased Activity, Foetal Distress Syndrome, Hypertonia Neonatal, Irritability, Leukocytosis
on Dec 21, 2007 Female patient from UNITED STATES , weighting 7.80 lb, was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, decreased activity, foetal distress syndrome, hypertonia neonatal, irritability, leukocytosis. Tofranil dosage: Maternal Dose 25 Mg Tid. During the same period patient was treated with RESLIN (Maternal Dose 25 Mg Tid) (View Reslin Review and Reslin Label ), AMOXAPINE (Maternal Dose 25 Mg Tid) (View Amoxapine Review and Amoxapine Label ), SOLANAX (Maternal Dose 0.4 Mg Once Daily) (View Solanax Review and Solanax Label ). Patient was hospitalized.

5572884-5 | Arrhythmia, Blood Pressure Decreased, Cardio-respiratory Arrest, Depressed Level Of Consciousness, Glossoptosis, Intubation, Life Support, Overdose, Shock
Patient was taking Tofranil (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), blood pressure decreased, cardio-respiratory arrest, depressed level of consciousness, glossoptosis, intubation, life support, overdose, shock on Dec 20, 2007 from JAPAN Additional patient health information: Female patient , 32 years of age, weighting 99.21 lb, was diagnosed with depression (What is depression?) and. Tofranil dosage: . During the same period patient was treated with TRIAZOLAM (3.25 Mg, Once/single) (View Triazolam Review and Triazolam Label ), CLOXAZOLAM (172 Mg, Once/single) (View Cloxazolam Review and Cloxazolam Label ), BROMAZEPAM (50 Mg, Once/single) (View Bromazepam Review and Bromazepam Label ), FLUNITRAZEPAM (20 Mg, Once/single) (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.